Cargando…

473. Clinical Outcomes of a Pediatric COVID Monoclonal Antibody Program based at an Urban Academic Center

BACKGROUND: Growing clinical evidence in adults has demonstrated use of COVID monoclonal antibody (mAB) therapy results in a reduction of hospitalization and/or emergency room (ER) visits with the greatest benefit following early administration. While the FDA has authorized use of mAB therapy in chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Philip J, Cruz, Carlos, Anosike, I J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690654/
http://dx.doi.org/10.1093/ofid/ofab466.672